# Bloomin' Brands, Inc.: financial statements, quarterly

BLMN · Nasdaq · CIK 1546417 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 27

Pages: [Overview](/companies/blmn.md) · [Financials](/companies/blmn/financials.md) · [Filings](/companies/blmn/filings.md) · [Insiders](/companies/blmn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/blmn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-24) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [942](/filings/0001546417-25-000034.md) | [1,072](/filings/0001546417-25-000034.md) | [1,069](/filings/0001546417-25-000103.md) | [999](/filings/0001546417-25-000111.md) | [910](/filings/0001546417-25-000141.md) | [972](/filings/0001546417-25-000034.md) | [1,050](/filings/0001546417-26-000026.md) | [1,002](/filings/0001546417-26-000032.md) | [929](/filings/0001546417-25-000141.md) | [975 d](/filings/0001546417-26-000009.md) | [1,060](/filings/0001546417-26-000026.md) | [1,016](/filings/0001546417-26-000032.md) |
| Cost of revenue | $m | [322](/filings/0001546417-24-000160.md) | [183 d](/filings/0001546417-26-000009.md) | [316](/filings/0001546417-25-000103.md) | [295](/filings/0001546417-25-000111.md) | [261](/filings/0001546417-25-000141.md) | [276 d](/filings/0001546417-26-000009.md) | [313](/filings/0001546417-26-000026.md) | [298](/filings/0001546417-26-000032.md) | [275](/filings/0001546417-25-000141.md) | [291 d](/filings/0001546417-26-000009.md) | [317](/filings/0001546417-26-000026.md) | [306](/filings/0001546417-26-000032.md) |
| Operating income | $m | [47.3](/filings/0001546417-25-000034.md) | [49.6](/filings/0001546417-25-000034.md) | [70.9](/filings/0001546417-25-000103.md) | [44.1](/filings/0001546417-25-000111.md) | [8.6](/filings/0001546417-25-000141.md) | [16.2](/filings/0001546417-25-000034.md) | [57.2](/filings/0001546417-26-000026.md) | [29.7](/filings/0001546417-26-000032.md) | [(36.4)](/filings/0001546417-25-000141.md) | [(13.3) d](/filings/0001546417-26-000009.md) | [59.1](/filings/0001546417-26-000026.md) | [38.3](/filings/0001546417-26-000032.md) |
| Income tax | $m | [(0.1)](/filings/0001546417-24-000160.md) | [(2.8) d](/filings/0001546417-26-000009.md) | [6.6](/filings/0001546417-25-000103.md) | [2.8](/filings/0001546417-25-000111.md) | [(8.0)](/filings/0001546417-25-000141.md) | [(13.5) d](/filings/0001546417-26-000009.md) | [0.9](/filings/0001546417-26-000026.md) | [(8.7)](/filings/0001546417-26-000032.md) | [(2.4)](/filings/0001546417-25-000141.md) | [(16.5) d](/filings/0001546417-26-000009.md) | [(10.3)](/filings/0001546417-26-000026.md) | [(6.7)](/filings/0001546417-26-000032.md) |
| Net income | $m | [44.5](/filings/0001546417-24-000160.md) | [43.3 d](/filings/0001546417-26-000009.md) | [(83.9)](/filings/0001546417-25-000103.md) | [28.4](/filings/0001546417-25-000111.md) | [6.9](/filings/0001546417-25-000141.md) | [(79.5) d](/filings/0001546417-26-000009.md) | [42.2](/filings/0001546417-26-000026.md) | [25.4](/filings/0001546417-26-000032.md) | [(45.9)](/filings/0001546417-25-000141.md) | [(13.5) d](/filings/0001546417-26-000009.md) | [55.7](/filings/0001546417-26-000026.md) | [31.3](/filings/0001546417-26-000032.md) |
| Diluted EPS | $ per share | [0.45](/filings/0001546417-23-000120.md) | not reported | [(0.96)](/filings/0001546417-25-000103.md) | [0.32](/filings/0001546417-25-000111.md) | [0.08](/filings/0001546417-25-000141.md) | not reported | [0.50](/filings/0001546417-26-000026.md) | [0.30](/filings/0001546417-26-000032.md) | [(0.54)](/filings/0001546417-25-000141.md) | not reported | [0.65](/filings/0001546417-26-000026.md) | [0.36](/filings/0001546417-26-000032.md) |
| Basic EPS | $ per share | [0.50](/filings/0001546417-23-000120.md) | not reported | [(0.96)](/filings/0001546417-25-000103.md) | [0.33](/filings/0001546417-25-000111.md) | [0.08](/filings/0001546417-25-000141.md) | not reported | [0.50](/filings/0001546417-26-000026.md) | [0.30](/filings/0001546417-26-000032.md) | [(0.54)](/filings/0001546417-25-000141.md) | not reported | [0.65](/filings/0001546417-26-000026.md) | [0.37](/filings/0001546417-26-000032.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-24) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [86.6](/filings/0001546417-23-000120.md) | [112](/filings/0001546417-25-000034.md) | [132](/filings/0001546417-24-000113.md) | [118](/filings/0001546417-24-000125.md) | [83.6](/filings/0001546417-24-000160.md) | [70.1](/filings/0001546417-26-000009.md) | [57.7](/filings/0001546417-25-000103.md) | [50.3](/filings/0001546417-25-000111.md) | [66.5](/filings/0001546417-25-000141.md) | [59.5](/filings/0001546417-26-000032.md) | [71.3](/filings/0001546417-26-000026.md) | [66.6](/filings/0001546417-26-000032.md) |
| Current assets | $m | [261](/filings/0001546417-23-000120.md) | [343](/filings/0001546417-25-000034.md) | [298](/filings/0001546417-24-000113.md) | [300](/filings/0001546417-24-000125.md) | [261](/filings/0001546417-24-000160.md) | [321](/filings/0001546417-26-000009.md) | [319](/filings/0001546417-25-000103.md) | [332](/filings/0001546417-25-000111.md) | [351](/filings/0001546417-25-000141.md) | [270](/filings/0001546417-26-000032.md) | [209](/filings/0001546417-26-000026.md) | [210](/filings/0001546417-26-000032.md) |
| Total assets | $m | [3,351](/filings/0001546417-23-000120.md) | [3,424](/filings/0001546417-25-000034.md) | [3,394](/filings/0001546417-24-000113.md) | [3,394](/filings/0001546417-24-000125.md) | [3,434](/filings/0001546417-24-000160.md) | [3,385](/filings/0001546417-26-000009.md) | [3,305](/filings/0001546417-25-000103.md) | [3,308](/filings/0001546417-25-000111.md) | [3,280](/filings/0001546417-25-000141.md) | [3,172](/filings/0001546417-26-000032.md) | [3,114](/filings/0001546417-26-000026.md) | [3,118](/filings/0001546417-26-000032.md) |
| Current liabilities | $m | [920](/filings/0001546417-23-000120.md) | [1,002](/filings/0001546417-25-000034.md) | [894](/filings/0001546417-24-000113.md) | [867](/filings/0001546417-24-000125.md) | [849](/filings/0001546417-24-000160.md) | [952](/filings/0001546417-26-000009.md) | [778](/filings/0001546417-25-000103.md) | [777](/filings/0001546417-25-000111.md) | [774](/filings/0001546417-25-000141.md) | [879](/filings/0001546417-26-000032.md) | [800](/filings/0001546417-26-000026.md) | [824](/filings/0001546417-26-000032.md) |
| Total liabilities | $m | [2,955](/filings/0001546417-23-000120.md) | [3,012](/filings/0001546417-25-000034.md) | [3,089](/filings/0001546417-24-000113.md) | [3,104](/filings/0001546417-24-000125.md) | [3,189](/filings/0001546417-24-000160.md) | [3,245](/filings/0001546417-26-000009.md) | [2,921](/filings/0001546417-25-000103.md) | [2,906](/filings/0001546417-25-000111.md) | [2,932](/filings/0001546417-25-000141.md) | [2,835](/filings/0001546417-26-000032.md) | [2,716](/filings/0001546417-26-000026.md) | [2,683](/filings/0001546417-26-000032.md) |
| Long-term debt | $m | [789](/filings/0001546417-23-000120.md) | [781](/filings/0001546417-25-000034.md) | [952](/filings/0001546417-24-000113.md) | [1,002](/filings/0001546417-24-000125.md) | [1,092](/filings/0001546417-24-000160.md) | [1,027](/filings/0001546417-26-000009.md) | [918](/filings/0001546417-25-000103.md) | [917](/filings/0001546417-25-000111.md) | [962](/filings/0001546417-25-000141.md) | [787](/filings/0001546417-26-000032.md) | [753](/filings/0001546417-26-000026.md) | [703](/filings/0001546417-26-000032.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [393](/filings/0001546417-23-000120.md) | [409](/filings/0001546417-25-000034.md) | [303](/filings/0001546417-24-000113.md) | [287](/filings/0001546417-24-000125.md) | [242](/filings/0001546417-24-000160.md) | [136](/filings/0001546417-26-000009.md) | [381](/filings/0001546417-25-000103.md) | [397](/filings/0001546417-25-000111.md) | [344](/filings/0001546417-25-000141.md) | [334](/filings/0001546417-26-000032.md) | [396](/filings/0001546417-26-000026.md) | [432](/filings/0001546417-26-000032.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-24) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [86.3 d](/filings/0001546417-24-000160.md) | [159 d](/filings/0001546417-26-000009.md) | [73.8](/filings/0001546417-25-000103.md) | [42.4 d](/filings/0001546417-25-000111.md) | [(7.8) d](/filings/0001546417-25-000141.md) | [120 d](/filings/0001546417-26-000009.md) | [73.5](/filings/0001546417-26-000026.md) | [49.7 d](/filings/0001546417-26-000032.md) | [34.4 d](/filings/0001546417-25-000141.md) | [119 d](/filings/0001546417-26-000009.md) | [75.3](/filings/0001546417-26-000026.md) | [90.9 d](/filings/0001546417-26-000032.md) |
| Capital expenditure | $m | [84.9 d](/filings/0001546417-24-000160.md) | [55.1 d](/filings/0001546417-26-000009.md) | [53.8](/filings/0001546417-25-000103.md) | [54.5 d](/filings/0001546417-25-000111.md) | [59.5 d](/filings/0001546417-25-000141.md) | [53.0 d](/filings/0001546417-26-000009.md) | [45.8](/filings/0001546417-26-000026.md) | [38.5 d](/filings/0001546417-26-000032.md) | [40.2 d](/filings/0001546417-25-000141.md) | [55.5 d](/filings/0001546417-26-000009.md) | [25.2](/filings/0001546417-26-000026.md) | [44.0 d](/filings/0001546417-26-000032.md) |
| Dividends paid | $m | [20.9 d](/filings/0001546417-24-000160.md) | [20.8 d](/filings/0001546417-26-000009.md) | [21.1](/filings/0001546417-25-000103.md) | [20.8 d](/filings/0001546417-25-000111.md) | [20.4 d](/filings/0001546417-25-000141.md) | [20.4 d](/filings/0001546417-26-000009.md) | [12.7](/filings/0001546417-26-000026.md) | [12.8 d](/filings/0001546417-26-000032.md) | [12.8 d](/filings/0001546417-25-000141.md) | [0.0 d](/filings/0001546417-26-000009.md) | [0.0](/filings/0001546417-26-000026.md) | [0.0 d](/filings/0001546417-26-000032.md) |
| Share repurchases | $m | [15.9 d](/filings/0001546417-24-000160.md) | [18.5 d](/filings/0001546417-26-000009.md) | [233](/filings/0001546417-25-000103.md) | [14.6 d](/filings/0001546417-25-000111.md) | [18.2 d](/filings/0001546417-25-000141.md) | [0.0 d](/filings/0001546417-26-000009.md) | [0.0](/filings/0001546417-25-000103.md) | [0.0 d](/filings/0001546417-25-000111.md) | [0.0 d](/filings/0001546417-25-000141.md) | [0.0 d](/filings/0001546417-26-000009.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-25) | Q1 FY2023 (2023-03-26) | Q2 FY2023 (2023-06-25) | Q3 FY2023 (2023-09-24) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [94.7](/filings/0001546417-23-000120.md) | [98.0](/filings/0001546417-24-000113.md) | [97.4](/filings/0001546417-24-000125.md) | [98.5](/filings/0001546417-24-000160.md) | [87.0](/filings/0001546417-25-000103.md) | [88.6](/filings/0001546417-25-000111.md) | [85.1](/filings/0001546417-25-000141.md) | [85.1](/filings/0001546417-26-000026.md) | [85.1](/filings/0001546417-26-000032.md) | [85.1](/filings/0001546417-25-000141.md) | [85.8](/filings/0001546417-26-000026.md) | [86.2](/filings/0001546417-26-000032.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 85,620,917 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001546417-26-000032.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.